The temperature dependence of four inorganic scintillation detectors was examined spectrally using the HYPERSCINT Research Platform 200 under 6 MV photon irradiations from a LINAC. After varying only the temperature of the detectors, all scintillators demonstrated linearity when the change in photon counts with temperature in the full-width at half maximum of their spectrum are integrated. Establishing the magnitude of the temperature dependence of the materials is critical to decide whether correction factors are required. This is especially true in applications such as brachytherapy, where detectors equilibrise to body temperature.
The purpose of this work is to evaluate the HYPERSCINT HS-RP100 scintillation dosimetry research platform designed for clinical quality assurance (QA) for use in in vivo dosimetry measurements. The device correctly detected the treatment error when the heads were intentionally laterally shifted. In three canine clinical patients treated in multiple fractions.
Accurate dosimetry in brachytherapy is not an easy task, as most detectors exhibit volume averaging or energy dependence reducing their usability. Free from these limitations are plastic scintillation detectors, which makes them well suited for brachytherapy applications, either for in vivo dosimetry or commissioning. This work aims to determine if the HYPERSCINT scintillation dosimetry research platform can be used for brachytherapy dose measurement in the context of commissioning a new brachytherapy technique.
Purpose was to characterize and validate the novel HYPERSCINT RP100 plastic dosimeter as a direct pulse counter and investigate its use as a real-time in-vivo dosimeter in FLASH-RT radiobiological experiments. In conclusions, the HYPERSCINT RP100 dosimeter accurately measured the delivered radiation absorbed dose under both characterization and biological experimental conditions, with a higher degree of reliability than conventional radiochromic film. Furthermore, its 500 Hz measurement frequency could directly and accurately measure the number of pulses delivered in real time. This shows its potential for real-time in-vivo dosimetry to verify accurate delivery during biological experiments and clinical treatments.
The accurate delivery of electrons at FLASH-RT dose rates in radiobiological experiments require new dosimeters that are capable of accurately measuring the radiation dose delivered at >0.55 Gy per pulse (>100 Gy/s) in real-time. The novel HYPERSCINT RP100 plastic dosimeter was able to accurately measure the delivered radiation absorbed dose under characterization and biological experimental conditions, with a higher degree of reliability than conventional radiochromic film. Furthermore, it was shown to directly and accurately measure the number of pulses delivered in real time. This shows potential for use as a real-time in-vivo dosimeter during biological experiments, as well as potential clinical applications.
The goal of this study was to prove the feasibility of using a single-fiber multipoint plastic scintillation detector as an in vivo verification tool during (192)Ir high-dose-rate brachytherapy treatments. The use of a multipoint plastic scintillation detector for high-dose-rate brachytherapy dosimetry is feasible. This detector shows great promise for development of in vivo applications for real-time verification of treatment delivery.
The goal of this study was to develop a novel multi-point plastic scintillation detector capable of measuring the dose accurately at multiple positions simultaneously using a single optical transmission line. This study demonstrates the practical feasibility of multi-point plastic scintillation detector. This type of detector could be very useful for pre-treatment quality assurance applications as well as an accurate tool for real-time in vivo dosimetry.
The purpose of this work is to evaluate the HYPERSCINT scintillation dosimetry research platform (Medscint Inc., Quebec City, Canada) designed for clinical QA for use in in-vivo dosimetry measurements.
FLASH-Radiotherapy is an emerging ultrahigh dose rates radiotherapy technique, and animal studies have demonstrated the safety and efficacy of the technique in cancer treatment. A reliable real-time dosimeter system is crucial for the characterization of the so-called ‘FLASH-effect’, and an accurate beam delivery. This study aims to benchmark the performance of optical fiber inorganic scintillating detectors (ISDs) with plastic scintillating detectors (PSDs) for an ultrahigh dose-rate x-ray beam irradiation. Measurements includes : relative scintillator output, signal linearity with dose and dose rate, signal-to-noise ratio (SNR), signal stability and reliability.
The PSDs resulted in the highest reliability for a UHDR beam measurement with a CV of <0.1% while the Gd2O2S:Tb showed excellent repeatability (coefficient of variation (CV) <0.1%) compared to other detectors. All detectors showed good linearity with tube current (R2 < 0.975) and shutter exposure (R2 >0.999).
FLASH radiation therapy using an ultrahigh dose-rate beam is found to eradicate tumours whilst significantly reducing radiation-induced tissue toxicity. A real-time dosimetry system is required for the technique to be implemented clinically and for further preclinical studies. This study aimed to optimize the design of scintillating detectors using inorganic materials for real-time dosimetry in ultrahigh dose-rate radiation applications. Inorganic scintillator detectors were fabricated using phosphor-based scintillating materials (Gd2O2S:Tb, La2O2S:Tb, and La2O2S:Eu) coupled with optical fibers. The initial results in ultrahigh dose-rate x-ray irradiation showed excellent linearity with signal independent of the dose rate and dose delivered. A hyperspectral approach is adopted in this study to account for the stem effect that occurs within the high energy typically used in radiotherapy.